Abstract:The study aimed to determine the expression of miR451 in colorectal cancer (CRC) subjects with CRC cells, and the role of miR451 in colorectal cancer cells. In October 2020, ATC purchased CRC and normal mucosal cell lines of CRC and implanted them in DMEM with 10% fetal serum. The suitability of the HT29 cell line is verified using the STR profile. In an incubator with 5% CO 2 , enlarged cells were placed at 37 °C. TCGA data was used to select the top 120 patients with a high voice and the lowest 120 patients with a low voice. Cells were collected and coated with Annexin V and PE according to the manufacturer’s instructions after 24.0 h. After that, the cells were separated. Cells were also tested using flow cytometry. HCT-120 cells were transplanted into a concentration of 5×105/ml cells in 6-source plates. HCT120 cells in the experimental group were combined with miR451 mimics, miR451 inhibitors, or miR451 miR + SMAD4B for 12 h at 37 °C, and cells were collected 24 h later at 37 °C. The sample was injected with 5 ml of Annexin VFITC and PE. Compared with normal colorectal mucosal cells, CRC cell lines decreased miR451 expression levels (fetal human cells (FHC) and HCoEpiC). Then, the HCT120 cells were transfected with miR451 inhibitors, and 72 h after transfection, say of miR451 was normal. There was a significant decrease in cell function in the miR451mimic groups, but an increase when the miR451 was blocked. The proliferation of cancer cells was prevented and chemotherapy was effective when miR451 was overexpressed. The SMAD4 gene provides instructions for making a protein involved in transmitting chemical signals from the cell surface to the nucleus. The SMAD4B expression was tested by RT-qPCR and Western blotting after 72.0 h of transmission. The mRNA and protein expression of SMAD4B decreased significantly when miR451 was significantly higher than when inhibited, as revealed in the results of this study. Seventy-two hours after transplantation, mRNA levels and SMAD4B proteins were measured in HCT120 cells. In addition, the researchers in this study investigated whether miR451 was associated with SMAD4B-directed control of CRC growth and migration. It was found that SMAD4B is highly expressed in both CRC and para-cancer tissues while using the TCGA database to detect SMAD4B expression. Patients with CRC with SMAD4B have a severe prognosis. MiR451 is sensitive to depressive disorders by targeting SMAD4B, according to these studies. We found that miR451 inhibited cell growth and migration, made CRC cells more readily available in chemotherapy, and did so by targeting SMAD4B. The findings suggest that miR451 and its genetic predisposition, SMAD4B, may help predict the prognosis and course of cancer patients. Treatments that target the miR451/SMAD4B axis may be helpful to people with CRC.

The TGF‐β/Smad2/3 signaling pathway is involved in Musashi2‐induced invasion and metastasis of colorectal cancer

Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer.

196P Expression of Musashi-1 Protein and Its Implications in Progression and Prognosis of Gastric Cancer

Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration

Musashi2 promotes the proliferation and migration of colorectal cancer by down-regulating Numb protein

Musashi-1 Enhances Glioblastoma Cell Migration and Cytoskeletal Dynamics through Translational Inhibition of Tensin3

Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.

Musashi-2 Deficiency Triggers Colorectal Cancer Ferroptosis by Downregulating the MAPK Signaling Cascade to Inhibit HSPB1 Phosphorylation

Increased Musashi 2 Expression Indicates a Poor Prognosis and Promotes Malignant Phenotypes in Gastric Cancer

Musashi1 Promotes Tumor Metastasis and is a Prognostic Marker for Renal Carcinoma

TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis

Musashi 2 Contributes to the Stemness and Chemoresistance of Liver Cancer Stem Cells Via LIN28A Activation.

Increased expression of the RNA-binding protein Musashi-2 is associated with immune infiltration and predicts better outcomes in ccRCC patients

To Assess the Role of Microrna-451 in the Progression and Metastasis of Colorectal Cancer

MSI2 Knockdown Represses Extrahepatic Cholangiocarcinoma Growth and Invasion by Inhibiting Epithelial-Mesenchymal Transition.

Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment

SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET

CCDC113 promotes colorectal cancer tumorigenesis and metastasis via TGF-β signaling pathway

Identification of BGN and THBS2 As Metastasis‐specific Biomarkers and Poor Survival Key Regulators in Human Colon Cancer by Integrated Analysis

Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation

SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression